Mouwasat
المواساةTechnical Analysis & Signals
Al-Mawassah stock shows an upward trend with positive signals in technical analysis.
Technical Analysis
Al-Mawassah stock shows a clear upward trend, currently trading at 71.1 SAR. The Relative Strength Index (RSI) at 61.2 indicates positive momentum, which may enhance the likelihood of the upward trend continuing.
Support & Resistance Levels
The main support level is at 70.0 SAR, while resistance is at 74.0 SAR. Breaking through the resistance level could present a good opportunity for investors to enter the stock.
Volume Analysis
Volume data has not been provided, but notable activity is expected if the upward trend continues. An increase in trading volume could strengthen the current price movement.
Fundamental Factors
The price-to-earnings (P/E) ratio at 18.8 indicates a reasonable valuation, while the dividend yield at 4.15% may attract investors. These fundamental factors could enhance the stock's appeal in the market.
Risk Factors
The company may face challenges related to market volatility or changes in economic policies. It is important to monitor any developments that could impact the stock's performance.
Recommendation
Disclaimer: This analysis is for educational purposes only and does not constitute investment advice. The stock is expected to continue its upward trend, but investors should conduct their own research.
Automated analysis is based on historical data and technical indicators and may not reflect future market conditions.
Financial Fundamentals
Price Data
Price Chart - Mouwasat
4002Technical Analysis
Moving Averages
Momentum Indicators
Bollinger Bands
Within BandTrend Strength (ADX)
Moderate TrendFinancial Summary
Valuation
- Market Cap
- 14.22B
- P/E Ratio
- 18.80
- P/B Ratio
- 3.80
- EPS (Earnings/Share)
- 3.78
Profitability
- Revenue
- 3.22B
- Net Income
- 822.04M
- Return on Equity (ROE)
- +20.00%
- Shares Outstanding
- 200.00M
Balance Sheet
- Total Assets
- N/A
- Total Debt
- 1.07B
- Debt/Equity
- 0.27
- Free Float %
- +45.4%
Dividends & Margins
- Dividend Yield
- +4.15%
- Dividend/Share
- 3.00
- Book Value
- 18.71
Financial data extracted from published quarterly reports. All values in SAR unless otherwise stated.
Historical Financial Data
4 years| Year | Revenue | Net Income | Total Assets | Total Debt | EPS |
|---|---|---|---|---|---|
| 2024 | 2.88B +6.4% | 645.76M -1.8% | 5.40B +8.8% | 761.68M -3.4% | 3.23 -1.8% |
| 2023 | 2.71B +15.9% | 657.69M +9.7% | 4.96B +6.5% | 788.48M -11.6% | 3.29 +9.7% |
| 2022 | 2.33B +8.9% | 599.31M +3.7% | 4.66B +14.8% | 892.16M +7.6% | 3.00 +3.8% |
| 2021 | 2.14B | 578.16M | 4.06B | 828.86M | 2.89 |
Historical data sourced from Yahoo Finance and may differ from official audited financial reports.
Price Forecast
These forecasts are based on technical analysis and AI and do not constitute investment advice. Past performance does not guarantee future results.
News & Events
Mouwasat says benefited from lower financing costs, expects Jeddah hospital opening this year
Mouwasat to commence operations at Yanbu hospital on Feb. 1
Mouwasat approves new hospital project worth SAR 900M in Riyadh
AlJazira Capital sets potential changes in MSCI February index review
Ubhar Capital issues Q4 2025 earnings forecasts
Saudi healthcare sector in Q4 2025: Key events likely to impact performance
Firms likely to declare cash dividends in Jan. based on historical pattern
A look at healthcare firms’ performance, financial indicators in Q3 2025
News source: Argaam (argaam.com)
Sector Comparison
| Symbol | Name | Price | Change% |
|---|---|---|---|
| 4013 | Dr. Sulaiman Al Habib | 249.10 SAR | |
| 4002 | Mouwasat | 71.10 SAR | |
| 4004 | Dallah Healthcare | 124.60 SAR | |
| 4017 | Fakeeh Care | 32.40 SAR | |
| 4018 | Almoosa | 137.10 SAR | |
| 4005 | CARE | 130.70 SAR | |
| 4019 | SMC Healthcare | 17.70 SAR | |
| 4007 | Alhammadi | 25.72 SAR |
Dividend History
Dividend data from Tadawul records. All amounts in SAR. Estimated yield calculated based on year-end price.
Ownership Structure
Data source: Yahoo FinanceLast updated: 2026-03-26
Risk Assessment
Risk Factors
Average True Range 2.9% of stock price
Trading volume near or above average
P/E ratio 18.8
Debt-to-equity ratio 0.27
ADX indicator at 31
Stable fundamentals, low volatility, and good financial solvency
This assessment is automated based on quantitative data and does not constitute investment advice. Please consult a licensed financial advisor before making investment decisions.
FAQ
1 What is Mouwasat stock price today?
Mouwasat (4002) stock price today is 71.10 SAR, declining by -1.66% compared to the previous session close. The 52-week price range is between 58.65 SAR and 79.55 SAR.
2 What is Mouwasat stock valuation?
The automated analysis signal for Mouwasat is "Buy" with 75% confidence. The P/E ratio is 18.8. The P/B ratio is 3.80.
3 Is Mouwasat Shariah-compliant?
Yes, Mouwasat (4002) is Shariah-compliant according to the latest lists approved by relevant Shariah authorities.
4 What are Mouwasat dividend distributions?
Mouwasat has a dividend yield of 4.15%, with an estimated annual dividend of 3.00 SAR per share.
5 What is Mouwasat weekly performance?
Mouwasat performance over different time periods: weekly change +2.30%, monthly +6.04%, and year-to-date +6.12%. The stock is currently trading with a volume of 551,567 shares.
6 What is the target level for Mouwasat?
According to automated analysis for Mouwasat: Short-term target (1-2 weeks): 73.00 SAR. Medium-term target (1-3 months): 76.00 SAR. Support level: 70.00 SAR. Resistance level: 74.00 SAR. Note: These are automated analytical levels and do not constitute investment advice.
Disclaimer
The information provided on this page is for educational and analytical purposes only and does not constitute investment advice or a recommendation to buy or sell. Past performance does not guarantee future results. All investments involve risk including loss of capital. Please consult a licensed financial advisor before making any investment decisions.
Automated analysis relies on historical data and technical indicators and may not reflect future market conditions.